Anxiolytic	B:C3179404
effects	I:C3179404
of	O
fluoxetine	B:C0016365
and	O
nicotine	B:C0028040
exposure	O
on	O
exploratory	O
behavior	O
in	O
zebrafish	B:C0043457
Zebrafish	B:C0043457
(	O
Danio	B:C0043457
rerio	I:C0043457
)	O
have	O
emerged	O
as	O
a	O
popular	O
model	O
for	O
studying	B:C2603343
the	O
pharmacology	O
and	O
behavior	O
of	O
anxiety	B:C0003467
.	O

While	O
there	O
have	O
been	O
numerous	O
studies	B:C2603343
documenting	O
the	O
anxiolytic	B:C3179404
and	O
anxiogenic	O
effects	O
of	O
common	O
drugs	B:C0013227
in	O
zebrafish	B:C0043457
,	O
many	O
do	O
not	O
report	B:C0684224
or	O
test	O
for	O
behavioral	O
differences	O
between	O
the	O
sexes	O
.	O

Previous	O
studies	B:C2603343
have	O
indicated	O
that	O
males	O
and	O
females	O
differ	O
in	O
their	O
baseline	O
level	O
of	O
anxiety	B:C0003467
.	O

In	O
this	O
study	B:C2603343
,	O
we	O
test	O
for	O
a	O
sex	O
interaction	O
with	O
fluoxetine	B:C0016365
and	O
nicotine	B:C0028040
.	O

We	O
exposed	O
fish	B:C0043457
to	O
system	B:C0043047
water	I:C0043047
(	O
control	O
)	O
,	O
10	O
mg	O
/	O
L	O
fluoxetine	B:C0016365
,	O
or	O
1	O
mg	O
/	O
L	O
nicotine	B:C0028040
for	O
three	O
minutes	O
prior	O
to	O
being	O
subjected	O
to	O
four	O
minutes	O
in	O
an	O
open	B:C0022885
-	I:C0022885
field	I:C0022885
drop	I:C0022885
test	I:C0022885
.	O

Video	O
recordings	O
were	O
tracked	O
using	O
ProAnalyst	B:C0037585
.	O

Fish	B:C0043457
from	O
both	O
drug	B:C0013227
treatments	O
reduced	O
swimming	O
speed	O
,	O
increased	O
vertical	B:C0444402
position	I:C0444402
,	O
and	O
increased	O
use	O
of	O
the	O
top	O
half	O
of	O
the	O
open	O
field	O
when	O
compared	O
with	O
the	O
control	O
,	O
though	O
fluoxetine	B:C0016365
had	O
a	O
larger	O
effect	O
on	O
depth	O
related	O
behaviors	O
while	O
nicotine	B:C0028040
mostly	O
affected	O
swimming	O
speed	O
.	O

A	O
significant	O
sex	O
effect	O
was	O
observed	O
where	O
females	O
swam	O
at	O
a	O
slower	O
and	O
more	O
constant	O
speed	O
than	O
males	O
,	O
however	O
neither	O
drug	B:C0013227
produced	O
a	O
sex	O
-	O
dependent	O
response	O
.	O

